GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline (GSK)GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk.com.

GlaxoSmithKline RSS Channel

Filters
List of articles in category GlaxoSmithKline
Title Published Date
GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets 13 December 2022
GSK announces positive Phase IIa study results for a new first-in-class candidate medicine for patients with tuberculosis 17 November 2022
GSK signs agreement to support pandemic preparedness in Europe 01 August 2022
GSK announces £1 billion R&D investment over ten years to get ahead of infectious diseases in lower-income countries 23 June 2022
GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community 01 December 2021
Less talk, more action: New report sponsored by ViiV Healthcare provides roadmap to achieve health equity by 2040 28 October 2021
GSK welcomes WHO recommendation for broad roll-out of its RTS,S/AS01e (RTS,S) malaria vaccine 06 October 2021
SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate 31 August 2021
Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrates improved immune response and protection in preclinical study 18 August 2021
GSK and Vir Biotechnology announce Joint Procurement Agreement with European Commission for COVID-19 treatment, sotrovimab 30 July 2021
GSK and Vir Biotechnology announce continuing progress of the COMET clinical development programme for sotrovimab 22 June 2021
Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate 28 May 2021
GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19 15 April 2021
GSK to support manufacture of Novavax' COVID-19 vaccine 30 March 2021
Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate 24 February 2021
GSK and Vir Biotechnology expand coronavirus collaboration to advance new therapeutics for influenza and other respiratory viruses 19 February 2021
GSK and CureVac to develop next generation mRNA COVID-19 vaccines 04 February 2021
Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19 15 January 2021
Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalised adults with COVID-19 17 December 2020
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine programme to improve immune response in the elderly 11 December 2020